ICD-10-CM Codes
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
D65-D69 Coagulation defects, purpura and other hemorrhagic conditions
D68- Other coagulation defects
2022 ICD-10-CM Diagnosis Code D68.3

2022 ICD-10-CM Diagnosis Code D68.3

Hemorrhagic disorder due to circulating anticoagulants

2016

2017

2018

2019

2020

2021

2022

Non-Billable/Non-Specific Code

D68.3 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
The 2022 edition of ICD-10-CM D68.3 became effective on October 1, 2021.
This is the American ICD-10-CM version of D68.3 - other international versions of ICD-10 D68.3 may differ.

The following code(s) above D68.3 contain annotation back-references

Annotation Back-References

In this context, annotation back-references refer to codes that contain:

that may be applicable to D68.3:

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change
2022 (effective 10/1/2021): No change

ICD-10-CM Codes Adjacent To D68.3

D64.81 Anemia due to antineoplastic chemotherapy

D64.89 Other specified anemias

D64.9 Anemia, unspecified

D65 Disseminated intravascular coagulation [defibrination syndrome]

D66 Hereditary factor VIII deficiency

D67 Hereditary factor IX deficiency

D68 Other coagulation defects

D68.0 Von Willebrand's disease

D68.1 Hereditary factor XI deficiency

D68.2 Hereditary deficiency of other clotting factors

D68.3 Hemorrhagic disorder due to circulating anticoagulants

D68.31 Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

D68.311 Acquired hemophilia

D68.312 Antiphospholipid antibody with hemorrhagic disorder

D68.318 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants

D68.4 Acquired coagulation factor deficiency

D68.5 Primary thrombophilia

D68.51 Activated protein C resistance

D68.52 Prothrombin gene mutation

D68.59 Other primary thrombophilia

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.